Clinical Trial Update: Resilience and Brain Health of Older Adults (MEDEX-2) [NA]

View source ↗

Summary

The MEDEX-2 clinical trial on resilience and brain health in older adults is currently enrolling by invitation for age-related cognitive decline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cognitive Decline

Snippet

Sponsor: Washington University School of Medicine | Conditions: Age-related Cognitive Decline | NA | Status: ENROLLING_BY_INVITATION